Long-term outcome after marrow transplantation for severe aplastic anemia

Blood

Volumn 91, Issue 10, 1998, Pages 3637-3645

  Deeg, H Joachim ^a,b   Leisenring, Wendy ^a   Storb, Rainer ^a   Nims, Janet ^a   Flowers, Mary E D ^a   Witherspoon, Robert P ^a   Sanders, Jean ^a   Sullivan, Keith M ^a  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; APLASTIC ANEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; CELL SURVIVAL; CHILD; DISEASE SEVERITY; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC CELL; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 0032525179     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.10.3637     Document Type: Article

References (46)

1. Santos GW: History of bone marrow transplantation. Clin Haematol 12:611, 1983
2. Thomas ED, Buckner CD, Banaji M, Clift RA, Fefer A, Flouraoy N, Goodell BW, Hickman RO, Lerner KG, Neiman PE, Sale GE, Sanders JE, Singer J, Stevens M, Storb R, Weiden PL: One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. Blood 49:511, 1977
3. Storb R, Thomas ED, Buckner CD, Clift RA, Johnson FL, Fefer A, Glucksberg H, Giblett ER, Lerner KG, Neiman P: Allogeneic marrow grafting for treatment of aplastic anemia. Blood 43:157, 1974
4. Storb R, Prentice RL, Thomas ED: Marrow transplantation for treatment of aplastic anemia. An analysis of factors associated with graft rejection. N Engl J Med 296:61, 1977
5. Gluckman E, Horowitz MM, Champlin RE, Hows JM. Bacigalupo A, Biggs JC, Camitta BM, Gale RP, Gordon-Smith EC, Marmont AM, Masaoka T, Ramsay NKC, Rimm AA, Rozman C, Sobocinski KA, Speck B, Bortin MM: Bone marrow transplantation for severe aplastic anemia: Influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 79:269, 1992
6. Storb R, Doney KC, Thomas ED, Appelbaum F, Buckner CD, Clift RA, Deeg HJ, Goodell BW, Hackman R, Hansen JA, Sanders J, Sullivan K, Weiden PL, Witherspoon RP: Marrow transplantation with or without donor buffy coat cells for 65 transfused aplastic anemia patients. Blood 59:236, 1982
7. Gluckman E, for the Advisory Committee of the International Bone Marrow Transplant Registry: Current status of bone marrow transplantation for severe aplastic anemia: A preliminary report from the International Bone Marrow Transplant Registry. Transplant Proc 19:2597, 1987
8. Ramsay NKC, Kim T, Nesbit ME, Krivit W, Coccia PF, Levitt SH, Woods WG, Kersey JH: Total lymphoid irradiation and cyclophosphamide as preparation for bone marrow transplantation in severe aplastic anemia. Blood 55:344, 1980
9. Deeg HJ, Storb R, Weiden PL, Raff RF, Sale GE, Atkinson K, Graham TC, Thomas ED: Cyclosporin A and methotrexate in canine marrow transplantation: Engraftment, graft-versus-host disease, and induction of tolerance. Transplantation 34:30, 1982
10. Storb R, Deeg HJ, Pepe M, Doney K, Appelbaum F, Beatty P, Bensinger W, Buckner CD, Clift R, Hansen J, Hill R, Longton G, Anasetti C, Martin P, Loughran TP, Sanders J, Singer J, Stewart P, Sullivan KM, Witherspoon R, Thomas ED: Graft-versus-host disease prevention by methotrexate combined with cyclosporin compared to methotrexate alone in patients given marrow grafts for severe aplastic anaemia: Long-term follow-up of a controlled trial. Br J Haematol 72:567, 1989
11. Storb R, Etzioni R, Anasetti C, Appelbaum FR, Buckner CD, Bensinger W, Bryant E, Clift R, Deeg HJ, Doney K, Flowers M, Hansen J, Martin P, Pepe M, Sale G, Sanders J, Singer J, Sullivan KM, Thomas ED, Witherspoon RP: Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia. Blood 84:941, 1994
12. Deeg HJ: Early and late complications of bone marrow transplantation. Curr Opin Oncol 2:297, 1990
13. Kolb HJ, Bender-Götze C: Late complications after allogeneic bone marrow transplantation for leukaemia. Bone Marrow Transplant 6:61, 1990
14. Deeg HJ: Delayed complications and long-term effects after bone marrow transplantation. Hematol Oncol Clin North Am 4:641, 1990
15. Hinterberger W, Rowlings PA, Hinterberger-Fischer M, Gibson J, Jacobsen N, Klein JP, Kolb HJ, Stevens DA, Horowitz MM, Gale RP: Results of transplanting bone marrow from genetically identical twins into patients with aplastic anemia. Ann Intern Med 126:116, 1997
16. Passweg JR, Socié G, Hinterberger W, Bacigalupo A, Biggs JC, Camitta BM, Champlin RE, Gale RP, Gluckman E, Gordon-Smith EC, Hows JM, Klein JP, Nugent ML, Pasquini R, Rowlings PA, Speck B, Tichelli A, Zhang M-J, Horowitz MM, Bortin MM: Bone marrow transplantation for severe aplastic anemia: Has outcome improved? Blood 90:858, 1997
17. Storb R: Bone marrow transplantation for aplastic anemia, in Forman SJ, Blume KG, Thomas ED (eds): Bone Marrow Transplantation. Boston, MA, Blackwell, 1994, p 583
18. Deeg HJ, Self S, Storb R, Doney K, Appelbaum FR, Witherspoon RP, Sullivan KM, Sheehan K, Sanders J, Mickelson E, Thomas ED: Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: Changing impact of risk factors. Blood 68:1363, 1986
19. Huss R, Deeg HJ, Gooley T, Bryant E, Leisenring W, Clift R, Buckner CD, Martin P, Storb R, Appelbaum FR: Effect of mixed chimerism on graft-versus-host disease, disease recurrence, and survival after HLA-identical marrow transplantation for aplastic anemia or chronic myelogenous leukemia. Bone Marrow Transplant 18:767, 1996
20. Thomas ED, Storb R, Clift RA, Fefer A, Johnson FL, Neiman PE, Lerner KG, Glucksberg H, Buckner CD: Bone-marrow transplantation. N Engl J Med 292:832, 1975
21. Martin PJ, Schoch G, Fisher L, Byers V, Anasetti C, Appelbaum FR, Beatty PG, Doney K, McDonald GB, Sanders JE, Sullivan KM, Storb R, Thomas ED, Witherspoon RP, Lomen P, Hannigan J, Hansen JA: A retrospective analysis of therapy for acute graft-versus-host disease: Initial treatment. Blood 76:1464, 1990
22. Sullivan KM, Witherspoon RP, Storb R, Anasetti C, Appelbaum FR, Bigelow C, Clark J, Doney K, Hill R, Loughran T, Matthews DD, Nims J, Petersen F, Sanders J. Schüning F, Shields A, Strom S, Thomas ED: Chronic graft-versus-host disease: Recent advances in diagnosis and treatment, in Gale RP, Champlin R (eds): Bone Marrow Transplantation: Current Controversies. UCLA Symposia on Molecular and Cellular Biology, New Series. New York, NY, Liss, 1989, p 511
23. Loughran TP Jr, Sullivan K, Morton T, Beckham C, Schubert M, Witherspoon R, Sale G, Sanders J, Fisher L, Shulman H, Thomas ED, Storb R: Value of day 100 screening studies for predicting the development of chronic graft-versus-host disease after allogeneic bone marrow transplantation. Blood 76:228, 1990
24. Bush NE, Haberman M, Donaldson G, Sullivan KM: Quality of life of 125 adults surviving 6-18 years after bone marrow transplantation. Soc Sci Med 40:479, 1995
25. Sanders JE, Hawley J, Levy W, Gooley T, Buckner CD, Deeg HJ, Doney K, Storb R, Sullivan K, Witherspoon R, Appelbaum FR: Pregnancies following high-dose cyclophosphamide with or without high-dose busulfan or total-body irradiation and bone marrow transplantation. Blood 87:3045, 1996
26. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
27. Pepe MS, Mori M: Kaplan-Meier, marginal or conditional probability curves in summarizing competing risks failure time data? Stat Med 12:737, 1993
28. Deeg HJ, Flournoy N, Sullivan KM, Sheehan K, Buckner CD, Sanders JE, Storb R, Witherspoon RP, Thomas ED: Cataracts after total body irradiation and marrow transplantation: A sparing effect of dose fractionation. Int J Radiat Oncol Biol Phys 10:957, 1984
29. Benyunes MC, Sullivan KM, Deeg HJ, Mori M, Meyer W, Fisher L, Bensinger R, Jack MK, Hicks J, Witherspoon R, Buckner CD, Hansen JA, Appelbaum FR, Storb R: Cataracts after bone marrow transplantation: Long-term follow-up of adults treated with fractionated total body irradiation. Int J Radiat Oncol Biol Phys 32:661, 1995
30. Deeg HJ, Socié G, Schoch G, Henry-Amar M, Witherspoon RP, Devergie A, Sullivan KM, Gluckman E, Storb R: Malignancies after marrow transplantation for aplastic anemia and fanconi anemia: A joint Seattle and Paris analysis of results in 700 patients. Blood 87:386, 1996
31. Sullivan KM, Shulman HM, Storb R, Weiden PL, Witherspoon RP, McDonald GB, Schubert MM, Atkinson K, Thomas ED: Chronic graft-versus-host disease in 52 patients: Adverse natural course and successful treatment with combination immunosuppression. Blood 57:267, 1981
32. Sullivan KM, Storek J, Kopecky KJ, Jocom J, Longton G, Flowers M, Siadak M, Nims J, Witherspoon RP, Anasetti C, Appelbaum FR, Bowden RA, Buckner CD, Crawford SW, Deeg HJ, Hansen JA, McDonald GB, Sanders JE, Storb R: A controlled trial of long-term administration of intravenous immunoglobulin to prevent late infection and chronic graft-vs.-host disease after marrow transplantation: Clinical outcome and effect on subsequent immune recovery. Biol Blood Marrow Transplant 2:44, 1996
33. Storb R, Prentice RL, Sullivan KM, Shulman HM, Deeg HJ, Doney KC, Buckner CD, Clift RA, Witherspoon RP, Appelbaum FR, Sanders JE, Stewart PS, Thomas ED: Predictive factors in chronic graft-versus-host disease in patients with aplastic anemia treated by marrow transplantation from HLA-identical siblings. Ann Intern Med 98:461, 1983
34. Hows J, Bradley B, Gore S, Downie T, Howard M: Results of unrelated donor BMT depends on choice of immunosuppressive protocol. Bone Marrow Transplant 15:A249, 1995 (suppl 2)
35. Andrykowski MA, Altmaier EM, Barnett RL, Otis ML, Gingrich R, Henslee-Downey PJ: The quality of life in adult survivors of allogeneic bone marrow transplantation. Transplantation 50:399, 1990
36. Ralph DD, Springmeyer SC, Sullivan KM, Hackman RC, Storb R, Thomas ED: Rapidly progressive air-flow obstruction in marrow transplant recipients: Possible association between obliterative bronchiolitis and chronic graft-versus-host disease. Am Rev Respir Dis 129:641, 1984
37. Schmidt GM, Niland JC, Forman SJ, Fonbuena PP, Dagis AC, Grant MM, Ferrell BR, Barr TA, Stallbaum BA, Chao NJ, Blume KG: Extended follow-up in 212 long-term allogeneic bone marrow transplant survivors. Transplantation 55:551, 1993
38. Baker F, Wingard JR, Curbow B, Zabora J, Jodrey D, Fogarty L, Legro M: Quality of life of bone marrow transplant long-term survivors. Bone Marrow Transplant 13:589, 1994
39. Wingard JR, Curbow B, Baker F, Piantadosi S: Health, functional status, and employment of adult survivors of bone marrow transplantation. Ann Intern Med 114:113, 1991
40. Claisse JP, Hirsch I, Gluckman E: Quality of life after an allogeneic bone marrow transplantation: The patient's point of view. Nouv Rev Fr Hematol 36:883, 1994 (suppl 1)
41. Chao NJ, Tierney DK, Bloom JR, Long GD, Barr TA, Stallbaum BA, Wong RM, Negrin RS, Horning SJ, Blume KG: Dynamic assessment of quality of life after autologous bone marrow transplantation. Blood 80:825, 1992
42. Frickhofen N, Kaltwasser JP, Schrezenmeier H, Raghavachar A, Vogt HG, Herrmann F, Freund M, Meusers P, Salama A, Heimpel H: Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. N Engl J Med 324:1297, 1991
43. Gluckman E, Esperou-Bourdeau H, Baruchel A, Boogaerts M, Briere J, Donadio D, Leverger G, Leporrier M, Reiffers J, Janvier M, Michallet M, Stryckmans P, Cooperative Group on the Treatment of Aplastic Anemia: Multicenter randomized study comparing cyclosporine-A alone and antithymocyte globulin with prednisone for treatment of severe aplastic anemia. Blood 79:2540, 1992
44. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B: Late haematological complications in severe aplastic anaemia. Br J Haematol 69:413, 1988
45. Doney K, Leisenring W, Storb R, Appelbaum FR, for the Seattle Bone Marrow Transplant Team: Primary treatment of acquired aplastic anemia: Outcomes with bone marrow transplantation and immunosuppressive therapy. Ann Intern Med 126:107, 1997
46. Langston AA, Sanders JE, Deeg HJ, Crawford SW, Anasetti C, Sullivan KM, Rowers MED, Storb R: Allogeneic marrow transplantation for aplastic anaemia associated with dyskeratosis congenita. Br J Haematol 92:758, 1996